Table 2.
Variable | Correlation Coefficient | p |
---|---|---|
Age | −0.05 | 0.34 |
Female Sex | 0.10 | 0.07 |
Black Race | −0.12 | 0.03 |
Current Smoker | 0.03 | 0.57 |
BMI | −0.02 | 0.77 |
Waist Circumference | −0.04 | 0.45 |
MAP | 0.06 | 0.26 |
Glucose | −0.04 | 0.44 |
Insulin* | 0.16 | 0.003 |
HOMA-IR* | 0.15 | 0.006 |
Total Cholesterol | 0.13 | 0.02 |
LDL-C | 0.05 | 0.38 |
HDL-C | 0.05 | 0.36 |
Triglycerides* | 0.21 | <0.0001 |
CRP* | 0.15 | 0.007 |
24-hour Urinary Sodium | −0.009 | 0.89 |
24-hour Urinary Na/Cr* | 0.06 | 0.28 |
hfPWV* | 0.07 | 0.21 |
baPWV* | 0.04 | 0.51 |
faPWV* | 0.06 | 0.26 |
Aldosterone and these variables were log transformed. MAP=mean arterial pressure, LDL-C=low density lipoprotein cholesterol, HDL-C=high density lipoprotein cholesterol, HOMA-IR= homeostasis model assessment of insulin resistance, CRP=C-reactive protein, Na/Cr= sodium/creatinine ratio, hfPWV=Heart-femoral pulse wave velocity, baPWV=Brachial-ankle pulse wave velocity, faPWV=Femoral-ankle pulse wave velocity. CRP, N=341; Triglycerides, N=343; 24-hour Urinary Sodium, N=281; 24-hour Urinary Sodium/Creatinine (Na/Cr), N=341; Heart-femoral PWV, N=335; Brachial-ankle PWV, N=338; Femoral-ankle PWV, N=322